Hinge Health
HNGE · NYSE · Healthcare
$94.90
+$0.18 (+0.19%) today
Market Cap
$7.66B
24h Volume
$461.5M
P/E Ratio
11.6
52w High
$94.90
52w Low
$31.17
Est. AI Revenue
30%
7-Day Sparkline (Static)
Company facts
Performance
About Hinge Health
Hinge Health delivers digital care for musculoskeletal conditions such as back and joint pain. Employers and health plans pay for the program as a covered benefit for their workforces, and members complete guided exercise therapy at home instead of visiting a physical therapist in person, which lowers the cost per case for the payer.
Its TrueMotion technology uses computer vision to track a member's movement through a smartphone camera, guiding exercise therapy without wearable sensors. AI-driven care automation handles much of the routine coaching and monitoring, supported by clinical care teams, while the Enso device provides drug-free electrical nerve stimulation for pain and HingeConnect integrates with medical records.
Founded in 2014, Hinge Health is headquartered in San Francisco, California, employs about 1,400 people, and listed on the NYSE in May 2025.
Hinge Health in the AI buildout
Hinge Health sits in the AI Healthcare layer as a case study in AI substituting for clinical labor. Computer vision replaces the trained eye of a physical therapist watching a patient move, and care automation handles routine coaching that once required human time. The company shows how AI shifts healthcare economics: more members served per clinician, delivered through software. Its exposure comes from AI being embedded in how care is delivered, not from selling AI tools to others.
HNGE is tracked in AI Healthcare, rated Growing on the AI Exposure leaderboard.
By the numbers
52-week range
HNGE trades at $94.90, 100% of the way up its 52-week range of $31.17 to $94.90.
Market cap
Market capitalization is $7.66B, with an AI Exposure Score of 48 out of 100.
Valuation vs peers
Its P/E ratio of 11.6 is below the AI Healthcare category median of 29.6.
Next earnings
Hinge Health is next expected to report earnings on November 3, 2026.
Market data as of the close on . Prices are end of day, not live.
Frequently asked questions
What does Hinge Health do?
Hinge Health provides digital treatment for musculoskeletal pain, such as back and joint conditions. Employers and health plans buy it as a benefit, and members do guided exercise therapy at home through an app instead of visiting clinics.
How is Hinge Health exposed to AI?
Supercycle rates Hinge Health as Growing with an AI Exposure Score of 48 out of 100. Computer vision and care automation genuinely power the product, but revenue comes from employer health contracts where AI is the enabler rather than the offering.
What is TrueMotion?
TrueMotion is Hinge Health's computer vision technology. It tracks a member's body movement through a smartphone camera during exercise sessions, checking form and counting repetitions without any wearable sensors, which lets therapy scale without in-person supervision.
Who leads Hinge Health?
Co-founder Daniel Perez is chief executive. He started the company in 2014 with Gabriel Mecklenburg and led it through its May 2025 listing on the NYSE. The company is headquartered in San Francisco.
Is HNGE a pure play AI stock?
No. Hinge Health is a Growing tier stock. AI is built into how it delivers care, but the business is digital health benefits sold to employers, and it competes on clinical outcomes and cost savings rather than AI technology itself.
Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.